First Tracks Biotherapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TRAX Nasdaq 2836 www.firsttracksbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for First Tracks Biotherapeutics, Inc.

First Tracks Biotherapeutics Announces $200 Million Private Placement - Oct 15th, 2026 6:00 am
Top biotechnology stock pick from Guggenheim - Oct 14th, 2026 12:54 pm
7 Reasons First Tracks Biotherapeutics (TRAX) Looks Pricey Following ANB033 Trial Data - Oct 13th, 2026 6:18 am
First Tracks Biotherapeutics (TRAX) Stock Looks Rich Following Phase 1b Celiac Data - Oct 13th, 2026 5:16 am
First Tracks Biotherapeutics (TRAX) Reports Positive Phase 1b Cohort 1 Results - Oct 13th, 2026 4:12 am
First Tracks climbs on ‘impressive’ celiac study data - Oct 12th, 2026 3:26 pm
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged - Oct 12th, 2026 2:10 pm
First Tracks’ ANB033 Clears Key Phase Ib Celiac Disease Study Goals - Oct 12th, 2026 11:02 am
First Tracks Biotherapeutics Shares Jump 20% After Positive Phase 1b Celiac Disease Trial Results - Oct 12th, 2026 6:44 am
Why Is First Tracks Biotherapeutics Stock Soaring Monday? - Oct 12th, 2026 6:23 am
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease - Oct 12th, 2026 5:00 am
First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026 - Oct 11th, 2026 2:00 pm
AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns? - Sep 25th, 2026 9:38 pm
Rosnilimab Emerges as a Potential Advance in Rheumatoid Arthritis as Physicians Look to the Next Wave of Pipeline Innovation - Sep 10th, 2026 6:52 am
First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Aug 26th, 2026 2:15 pm
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update - Aug 12th, 2026 2:15 pm
TRAX Stock Hits All-Time High — What's Driving The Super Rally? - Jul 10th, 2026 10:14 am
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - May 21st, 2026 2:15 pm
How The Grupo Traxión (BMV:TRAXION A) Story Is Shifting With Cautious New Analyst Targets - May 15th, 2026 8:18 am
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update - May 14th, 2026 2:15 pm